4//SEC Filing
Ho Tony W 4
Accession 0001209191-21-019157
CIK 0001674416other
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 5:40 PM ET
Size
7.0 KB
Accession
0001209191-21-019157
Insider Transaction Report
Form 4
Ho Tony W
See Remarks
Transactions
- Exercise/Conversion
Common Shares
2021-03-05+3,333→ 37,447 total - Tax Payment
Common Shares
2021-03-05$114.65/sh−1,585$181,720→ 35,862 total
Footnotes (4)
- [F1]On March 5, 2019, the reporting person was granted 10,000 restricted stock units. On March 5, 2021, 3,333 restricted stock units vested.
- [F2]Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
- [F3]Includes 150 shares acquired under the CRISPR Therapeutics AG 2016 Employee Stock Purchase Plan.
- [F4]Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.
Documents
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0001713637
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 5:40 PM ET
- Size
- 7.0 KB